[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT06356168":3,"trial-entities:NCT06356168":82,"trial-summary:NCT06356168":86},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":21,"primary_purpose":22,"phases":23,"enrollment_info":25,"interventions":28,"primary_outcomes":38,"secondary_outcomes":43,"sex":44,"minimum_age":45,"maximum_age":45,"healthy_volunteers":15,"eligibility_criteria":46,"std_ages":54,"locations":58,"central_contacts":73,"overall_officials":77,"references":80,"see_also_links":81},"NCT06356168","SVR\u002FIVR","Virtual Reality in End Stage Kidney Disease","Social Virtual Reality to Alleviate Loneliness and Symptoms for Individuals Receiving Hemodialysis","RECRUITING","2026-12-31","2026-07","2026-07-10","2026-03-30","University of Pennsylvania","OTHER",false,"The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.","In a single site, 2-arm (Social Virtual Reality group; Individual Virtual Reality Group), parallel, randomized controlled trial we will enroll 60 subjects (n=30 per group) to assess the effects of Social Virtual Reality to Individual Virtual Reality on symptoms in participants with end stage kidney disease who are receiving hemodialysis.\n\nTo compare the effects of social virtual reality to individual virtual reality on loneliness To explore the effects of social virtual reality to individual virtual reality on anxiety and depression.\n\nTo compare the effects social virtual reality to individual virtual reality on quality of life.",[19],"End Stage Kidney Disease",[],"INTERVENTIONAL","TREATMENT",[24],"NA",{"count":26,"type":27},60,"ESTIMATED",[29,34],{"type":30,"name":31,"description":32,"armGroupLabels":33},"BEHAVIORAL","Social Virtual Reality","Participants interact using virtual reality during dialysis.",[31],{"type":30,"name":35,"description":36,"armGroupLabels":37},"Individual Virtual Reality","Participants use virtual reality alone during dialysis.",[35],[39],{"measure":40,"description":41,"timeFrame":42},"De Jong Gierveld Scale","Measures how bad or severe a person's loneliness is. Score range from 11-44; higher scores indicate more loneliness.","Baseline and 4 Weeks",[],"ALL",null,{"inclusion":47,"exclusion":49,"raw_text":53},[48],"Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month",[50,51,52],"Acutely ill","Active nausea","Epilepsy","Inclusion Criteria\n\n* Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month\n\nExclusion Criteria\n\n* Acutely ill\n* Active nausea\n* Epilepsy",[55,56,57],"CHILD","ADULT","OLDER_ADULT",[59],{"facility":13,"status":8,"city":60,"state":61,"zip":62,"country":63,"contacts":64,"geoPoint":70},"Philadelphia","Pennsylvania","19104","United States",[65],{"name":66,"role":67,"phone":68,"email":69},"Lea Ann Matura","CONTACT","713-410-1325","matura@nursing.upenn.edu",{"lat":71,"lon":72},39.95238,-75.16362,[74],{"name":75,"role":67,"phone":76,"email":69},"Lea Ann Matura, PhD","2157468819",[78],{"name":75,"affiliation":13,"role":79},"PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":83,"biomarkers":85},[84],"Chronic Kidney Disease, Stage 5",[],{"nct_id":4,"found":87,"summary":88,"prompt_version":98},true,{"design":89,"status":90,"heading":91,"summary":92,"follow_up":93,"word_count":94,"commitments":95,"compensation":96,"drugs_mentioned":97},"This is a randomized controlled trial with two groups, aiming to enroll 60 participants. Participants will be randomly assigned to either the Social Virtual Reality group or the Individual Virtual Reality group.","completed","Virtual Reality for End Stage Kidney Disease","This study is exploring if using virtual reality (VR) during dialysis can help patients with end-stage kidney disease feel better. Researchers are comparing two types of VR: Social Virtual Reality, where you interact with others in a virtual world, and Individual Virtual Reality, where you use VR alone. The main goal is to see if there are differences in symptoms, especially loneliness, between these two groups. You might be able to join if you have end-stage kidney disease and receive hemodialysis three times a week for at least one month. You would use VR glasses for 30-45 minutes during your dialysis sessions for four weeks. The study is currently recruiting participants.","Your symptoms will be measured at baseline and again after 4 weeks.",111,"You would use virtual reality glasses for 30-45 minutes during your dialysis sessions for four weeks. Your symptoms will be measured at the beginning and after four weeks.","Not stated in the trial record.",[31,35],"v2"]